News

Under the terms of the agreement, Endo will pay Alexza an upfront fee of $10 million, with additional payments of up to $40 million upon achievement of predetermined

Under the terms of the settlement agreement, the company will transfer to PDG the leases and associated tangible assets with respect to 25 of 31 Park Dental facilities

Under the terms of the agreement, Source MDx and Pfizer will collaborate on a series of clinical studies in oncology and inflammation. Source MDx will receive an equity

Nutra Pharma’s wholly-owned medical devices subsidiary, Designer Diagnostics, is currently planning to undergo third party validation for its nontuberculous mycobacterium (NTM) diagnostic test kits at Tuberculosis Research Institute,

Brian Smithgall, managing director, Image Labs International, said: “The mobile imaging systems are being sold under our key customer program which provides added value to customers that request

By agreeing to a series of transactions, the minority shareholders will immediately assume management of Nyer and will control approximately 58% of the voting power of Nyer. Karen

The first patients have been enrolled and have undergone initial treatment steps in preparation for receiving DCVax-L. The trial involves two sequential studies, and comprises an innovative combination

The laboratory developed test performed on a real-time PCR platform to detect Rhesus D (RhD) incompatibility will be marketed by Sequenom’s nonexclusive licensee, CLIA-certified, Lenetix Medical Screening Laboratory

Mr. Karr has entered into a consulting agreement with the company and will remain a member of the company’s board of directors. Mr. Karr said: “I am proud